Goh C - The recent focus in the management of RA has been to treat early and intensively to reduce the burden of disease. Anti-cyclic citrullinated peptide (anti-CCP) antibodies have helped greatly in this endeavour and have also given us insights into the pathophysiology of the condition. This article will highlight the importance of knowing about these pivotal antibodies.